Transfusion and pulmonary morbidity after cardiac surgery

Area of Science:

• Cardiology
• Pulmonology
• Transfusion Medicine

Background:

• Transfusion-related acute lung injury (TRALI) is a significant cause of transfusion-related mortality.
• Pulmonary complications after cardiac surgery are common but often confounded by cardiopulmonary bypass and cardiac events.
• Diagnosing TRALI in cardiac surgery patients presents unique challenges.

Purpose of the Study:

• To determine the prevalence of transfusion-related pulmonary morbidity in cardiac surgery patients.
• To assess the applicability of TRALI consensus criteria to this population.

Main Methods:

• Analysis of 16,847 patients undergoing on-pump cardiac surgery (CABG, valve, or combined).
• Propensity-score-matched logistic regression analyses for red blood cell (RBC) and fresh frozen plasma (FFP) transfusions.
• Outcomes included pulmonary morbidity and the PaO2/FiO2 ratio.

Main Results:

• RBC and FFP transfusions were associated with increased risk-adjusted pulmonary complications (e.g., respiratory distress, failure, longer intubation).
• Acute Respiratory Distress Syndrome (ARDS) incidence was higher in transfused patients (0.64% vs. 0.21%).
• While many patients met the PaO2/FiO2 < 300 criterion for lung injury, it was largely unrelated to transfusion status.

Conclusions:

• Transfusion is associated with various postoperative pulmonary complications in cardiac surgery.
• The PaO2/FiO2 ratio, a key TRALI criterion, is not a reliable indicator of transfusion-related lung injury in this context.
• TRALI diagnosis using consensus criteria is problematic in cardiac surgery due to confounding factors.